Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals

Introduction Evidence suggests use of fluoroquinolones is associated with carbapenem resistance in Pseudomonas aeruginosa , and fluoroquinolone use has been identified as a risk factor for clinical acquisition of imipenemresistant P. aeruginosa in single-center studies. Imipenem susceptibility and f...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Advances in therapy 2011-04, Vol.28 (4), p.326-333
Hauptverfasser:	Eagye, Kathryn J., Nicolau, David P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Cardiology Cross Infection - microbiology Cross Infection - prevention & control Drug Resistance, Microbial - drug effects Endocrinology Fluoroquinolones - administration & dosage Fluoroquinolones - adverse effects Health technology assessment Hospitals, Teaching - statistics & numerical data Humans Imipenem - administration & dosage Imipenem - adverse effects Infection Control - statistics & numerical data Internal Medicine Medicine Medicine & Public Health Microbial Sensitivity Tests Oncology Original Research Pharmacology/Toxicology Pseudomonas aeruginosa Pseudomonas aeruginosa - drug effects Pseudomonas aeruginosa - pathogenicity Pseudomonas Infections - drug therapy Pseudomonas Infections - epidemiology Pseudomonas Infections - microbiology Retrospective Studies Rheumatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!